Drägerwerk AG Reports Significant Earnings Growth in Q1 2026

Drägerwerk AG & Co. KGaA has announced its preliminary financial figures for the first quarter of 2026, highlighting a notable improvement over the previous year. The company's net sales rose by 6.9% when adjusted for currency effects, reaching approximately EUR 766 million, a rise of EUR 26 million from the same period in 2025.

The medical division saw an increase of 5.4% in net sales, while the safety division posted an 8.8% growth. Earnings before interest and taxes (EBIT) surged to around EUR 18 million, with the EBIT margin climbing to 2.4%. This was primarily driven by a better sales performance and an enhancement in the gross margin to 46.3%.

Order intake also increased by 3.4%, reaching EUR 865 million. For the full year 2026, Dräger anticipates a net sales growth between 1.0% and 5.0% and an EBIT margin ranging from 5.0% to 7.5%. The full results for the first quarter are scheduled for release on April 30, 2026.